Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $3.25 $4.30 Thursday, 9th May 2024 GERN stock ended at $3.88. This is 1.84% more than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 3.16% from a day low at $3.80 to a day high of $3.92.
90 days $1.64 $4.30
52 weeks $1.64 $4.30

Historical Geron Corporation prices

Date Open High Low Close Volume
May 31, 2016 $2.86 $2.97 $2.85 $2.96 2 336 727
May 27, 2016 $2.82 $2.85 $2.75 $2.85 1 073 420
May 26, 2016 $2.94 $2.94 $2.81 $2.81 2 141 751
May 25, 2016 $2.93 $3.03 $2.90 $2.94 2 204 222
May 24, 2016 $2.87 $2.93 $2.83 $2.92 1 599 985
May 23, 2016 $2.82 $2.93 $2.79 $2.84 1 336 922
May 20, 2016 $2.72 $2.82 $2.72 $2.82 1 617 691
May 19, 2016 $2.80 $2.84 $2.68 $2.68 1 640 197
May 18, 2016 $2.73 $2.88 $2.73 $2.81 1 456 540
May 17, 2016 $2.74 $2.84 $2.72 $2.74 1 596 030
May 16, 2016 $2.69 $2.81 $2.66 $2.76 1 804 457
May 13, 2016 $2.64 $2.73 $2.61 $2.64 1 800 326
May 12, 2016 $2.77 $2.79 $2.63 $2.63 2 149 824
May 11, 2016 $2.80 $2.87 $2.75 $2.75 1 433 318
May 10, 2016 $2.80 $2.90 $2.74 $2.82 1 449 816
May 09, 2016 $2.66 $2.81 $2.66 $2.77 1 870 524
May 06, 2016 $2.65 $2.76 $2.59 $2.67 1 970 347
May 05, 2016 $2.75 $2.79 $2.67 $2.70 2 031 622
May 04, 2016 $2.83 $2.85 $2.69 $2.73 3 137 887
May 03, 2016 $2.98 $3.00 $2.84 $2.84 2 144 471
May 02, 2016 $2.99 $3.01 $2.88 $3.00 1 626 474
Apr 29, 2016 $3.04 $3.10 $2.93 $2.95 1 816 356
Apr 28, 2016 $3.08 $3.16 $3.03 $3.04 1 530 320
Apr 27, 2016 $3.14 $3.14 $3.02 $3.09 1 065 950
Apr 26, 2016 $3.23 $3.27 $3.06 $3.11 2 052 216
Click to get the best stock tips daily for free!

About Geron Corporation

Geron Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hematologic myeloid malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes a... GERN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT